Conduite à tenir devant une monocytose de l’adulte (notice n° 83690)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03420cam a2200361 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250112000422.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Labrousse, Julien |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Conduite à tenir devant une monocytose de l’adulte |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2019.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 73 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | RésuméLa constatation d’une monocytose est un phénomène fréquent, qui nécessite confirmation par lecture au microscope par un biologiste aguerri, permettant de s’affranchir des pièges cytologiques classiques comme la présence de tricholeucocytes, de cellules de Sézary ou de blastes monocytaires. Dans la grande majorité des cas l’origine réactionnelle est très facilement mise en évidence par le contexte et/ou la présence d’un syndrome inflammatoire biologique. Plus rarement le diagnostic est orienté vers une pathologie à éosinophiles ou une leucémie aiguë. Dans les autres cas, LMMC, NMP ou SMD avec monocytose pourront être évoquées. En l’absence d’élément diagnostique de certitude et la présence de formes « frontières » le diagnostic différentiel entre ces 3 entités n’est pas toujours simple, nécessitant, selon l’Organisation mondiale de la santé (OMS) investigations moléculaires et élimination de toute cause réactionnelle de monocytose. Bien que les études anatomo-pathologiques et phénotypiques par cytométrie en flux ne soient actuellement pas recommandées par l’OMS, ces investigations ont probablement un intérêt dans l’évaluation des cas difficiles. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | The discovery of a monocytosis is a frequent phenomenon, requiring confirmation by reading under a microscope by an experimented biologist, to overcome usual cytological traps such as the presence of hairy cells, promonocytes or monoblasts. In the vast majority of cases the secondary origin is very easily found by the context and/or the presence of a biological inflammatory syndrome. More rarely the diagnosis is directed towards an eosinophilic pathology or an acute leukemia. In other cases, CMML, MPN or MDS with monocytosis may be highlighted. In the absence of any pathognomonic element and the presence of “borderline” forms the differential diagnosis between these 3 entities is not always straightforward, requiring, according to WHO, molecular investigations and elimination of any reactive cause of monocytosis. Although histological, immunohistochemical and phenotypic flow cytometric studies are not currently recommended by WHO, these investigations could be of interest in the evaluation of difficult cases. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | néoplasies myéloprolifératives |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | monocytes |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | leucémie myélomonocytaire chronique |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | monocytose |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | chronic myelomonocytic leukemia |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | monocytes |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | monocytosis |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | myeloproliferative neoplasms |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pasini, Sophie |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Vignon, Guillaume |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bonnin, Anthony |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mottaz, Philippe |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Carrere, François |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Augereau, Pierre-Frédéric |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Aucher, Philippe |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lellouche, Franck |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Annales de Biologie Clinique | 77 | 5 | 2019-09-01 | p. 485-494 | 0003-3898 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-annales-de-biologie-clinique-2019-5-page-485?lang=fr">https://shs.cairn.info/revue-annales-de-biologie-clinique-2019-5-page-485?lang=fr</a> |
Pas d'exemplaire disponible.
Réseaux sociaux